|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.375 HKD | -1.30% |
|
-4.39% | -0.65% |
| 08-04 | CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China | MT |
| 08-03 | CSPC Pharma Begins Phase Ib/II Trial of Colorectal Cancer Drug Candidate | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 11.47 | +35.19% | 21 | ||||||
| 1,276.96 | +14.46% | 26 | ||||||
| 271.73 | +6.59% | 22 | ||||||
| 272.18 | +11.64% | 28 | ||||||
| 363.92 | +1.74% | 18 | ||||||
| 153.98 | +0.05% | 21 | ||||||
| 211.35 | +33.89% | 22 | ||||||
| 317.2 | +3.12% | 24 | ||||||
| 357.03 | -8.46% | 29 | ||||||
| 157.15 | +16.19% | 27 | ||||||
| 28.79 | +13.29% | 26 | ||||||
| 66.21 | +0.48% | 24 | ||||||
| 558.68 | +16.71% | 25 | ||||||
| 21.51 | +12.37% | 20 | ||||||
| 94.45 | +26.97% | 23 | ||||||
| 9,686.67 | +45.01% | 15 | ||||||
| 6,375.19 | +20.61% | 16 | ||||||
| 55.58 | +15.2% | 18 | ||||||
| 80.33 | +50.38% | 15 | ||||||
| 4.178 | +16.79% | 17 | ||||||
| Average | 1,018.23 | +16.61% | 22 | ||||||
| Weighted average by Cap. | 695.16 | +11.54% | 24 |
- Stock Market
- Stocks
- 1093 Stock
- Sector CSPC Pharmaceutical Group Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
